None
Language: English
Explore a promising new treatment for acute myeloid leukemia (AML) using CD37 as a drug delivery target This podcast discusses the research and potential benefits of this targeted therapy
Explore cutting-edge advancements in theranostics for treating hematologic cancers like leukemia and lymphoma focusing on targeted therapies and radioimmunotherapy. We discuss the potential and limitations of CXCR4-targeted therapies and the importance of accessibility and safety.
Note: If the podcast is yours, make sure it is not set to "private" before sharing. You can change this setting in "My Podcasts" on the left Menu.